Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (258) clinical trials

Alzheimer's disease is the most common neurodegenerative disorder and its prevalence steeply increases. The small number of effective treatments for Alzheimer's disease highlights a need for further research into novel therapeutic possibilities. Glutamate-mediated excitotoxicity in neuropsychiatric disorders and in particular in Alzheimer's disease has been shown to cause significant cerebral ...

Phase

Do you get lost easily in new places? Do you have a greater tendency to misplace things? Do other people notice that you are forgetful? Have you been diagnosed with Alzheimer's disease? If you are age 60 or over, having memory problems, or already diagnosed with Alzheimer's Disease, currently taking ...

Phase N/A

Consider participating in a clinical research study to evaluate the effectivness and safety of an oral study drug that may help slow the progression of mild to moderate Alzheimer's disease. To participate, you must be 55 to 85 years old with symptoms of mental or functional decline dating back at ...

Phase N/A

This study will evaluate the effects of daily dosing of AC-1204 on cognition, activities of daily living, resource utilization, quality of life, pharmacokinetic measures and safety among participants with mild to moderate Alzheimer's Disease Inclusion Criteria: Dementia status of mild to moderate CT or MRI scan within 18 months prior ...

Phase

MD Clinical is conductiong a 26-week, placebo-controlled research study of the safety & efficacy of an investigational drug for Alzheimer's Disease. Study-related exams & study drugs are provided at no cost. Qualified participants & caregivers will be compensated for time & travel.

Phase N/A

This is a multicenter, multinational study that be conducted to test the safety and effectiveness of an investigational medication against placebo ( a substance that looks like the study drug but does not contain the active ingredient) in patients with memory loss due to mild cognitive impairment or mild Alzheimer's ...

Phase

This is a 78 week double blind, placebo controlled to evaluate the safety and efficacy of an investigational medication as a potential disease modifying therapy in patients with mild to moderate Alzheimer's disease.

Phase N/A

EXPEDITION 3 will look at whether the investigational drug solanezumab can help slow the worsening of AD in patients with mild disease. Study duration will be approximately 18 months, followed by an optional open-label extension study. Participants will be randomized in a 1:1 ratio to receive solanezumab or placebo by ...

Phase

Are you or someone you care for experiencing memory loss possibly due to Alzheimer's disease?

Phase

Researchers are conducting a local research study for an investigational drug in people with mild Alzheimer's disease.

Phase